Global Health Impact Fund

Global Health Impact Fund (GHIF) is a clinician-founded venture capital firm based in Silicon Valley, specializing in early-stage healthcare startups. The firm leverages its deep medical and industry expertise to identify and support transformative healthtech companies. GHIF's investment process is supported by the Global Health Impact Network (GHIN), an expert network of over 2,000 clinicians across 40 different medical fields. This network-driven approach enables GHIF to provide unparalleled support to its portfolio companies, including critical business connections, mentoring, and funding.

GHIF focuses on sectors such as precision medicine, biotechnology, medical devices, diagnostics, and digital health. The firm invests in companies at various stages, from seed to growth, and has a geographical focus on the United States and Europe. GHIF's clinician-driven approach ensures that investments are aligned with the latest medical advancements and address pressing healthcare challenges. The firm is committed to improving global health outcomes by supporting innovations that have the potential to make a significant impact on patient care and treatment.

GHIF's portfolio includes companies like Somnoware, Elucid, and Raydiant Oximetry, Inc., which are developing innovative solutions in healthcare. The firm's investment philosophy emphasizes a hands-on approach, working closely with founders to bring products to market and improve patient outcomes. GHIF's team, based in Silicon Valley, combines over seventy-five years of experience in business and healthcare, making it a trusted partner for entrepreneurs aiming to transform the healthcare industry.